SABBY MANAGEMENT, LLC - INTRA CELLULAR THERAPIES INC ownership

INTRA CELLULAR THERAPIES INC's ticker is and the CUSIP is 46116X901. A total of 4 filers reported holding INTRA CELLULAR THERAPIES INC in Q3 2016. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
SABBY MANAGEMENT, LLC ownership history of INTRA CELLULAR THERAPIES INC
ValueSharesWeighting
Q4 2020$318,000
+23.7%
100
-36.7%
0.06%
+335.7%
Q1 2017$257,000
-90.4%
158
-91.1%
0.01%
-91.0%
Q4 2016$2,688,000
+231.0%
1,781
+234.1%
0.16%
+420.0%
Q3 2016$812,000
-84.8%
533
-61.2%
0.03%
-89.2%
Q2 2016$5,330,000
+87.9%
1,373
+34.6%
0.28%
+95.8%
Q1 2016$2,836,000
+427.1%
1,020
+920.0%
0.14%
+373.3%
Q4 2015$538,000
-90.3%
100
-92.7%
0.03%
-86.8%
Q3 2015$5,518,000
+51.4%
1,378
+20.8%
0.23%
+70.7%
Q2 2015$3,645,0001,1410.13%
Other shareholders
INTRA CELLULAR THERAPIES INC shareholders Q3 2016
NameSharesValueWeighting ↓
GROUP ONE TRADING, L.P. 28,000$1,303,0000.00%
JANE STREET GROUP, LLC 120,900$5,625,0000.00%
SIMPLEX TRADING, LLC 20,900$972,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of INTRA CELLULAR THERAPIES INC shareholders